Kestra Medical Technologies (NASDAQ:KMTS) Insider Traci Umberger Sells 100,000 Shares of Company Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) insider Traci Umberger sold 100,000 shares of Kestra Medical Technologies stock in a transaction on Wednesday, October 21st. The stock was sold at an average price of $27.18, for a total transaction of $2,718,000.00. Following the completion of the transaction, the insider owned 195,825 shares in the company, valued at $5,322,523.50. This trade represents a 33.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Kestra Medical Technologies Price Performance

KMTS opened at $28.32 on Friday. The business has a 50 day moving average of $26.42 and a 200-day moving average of $23.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 4.69 and a quick ratio of 4.69. Kestra Medical Technologies, Ltd. has a 1-year low of $17.34 and a 1-year high of $30.00.

Kestra Medical Technologies (NASDAQ:KMTS) last announced its quarterly earnings data on Monday, September 14th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.14). The firm had revenue of $30.97 million during the quarter. Kestra Medical Technologies had a negative return on equity of 63.83% and a negative net margin of 140.43%. On average, equities analysts expect that Kestra Medical Technologies, Ltd. will post -2.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Kestra Medical Technologies

Several institutional investors have recently modified their holdings of KMTS. Sterling Capital Management LLC lifted its stake in Kestra Medical Technologies by 834.0% in the third quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock valued at $25,000 after buying an additional 784 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Kestra Medical Technologies by 6.6% in the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock valued at $1,844,000 after buying an additional 5,731 shares during the period. California State Teachers Retirement System boosted its holdings in shares of Kestra Medical Technologies by 39.2% in the first quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock valued at $555,000 after buying an additional 7,844 shares during the period. Quantinno Capital Management LP bought a new stake in shares of Kestra Medical Technologies during the first quarter worth $431,000. Finally, Bank of New York Mellon Corp increased its position in shares of Kestra Medical Technologies by 47.2% during the first quarter. Bank of New York Mellon Corp now owns 70,113 shares of the company’s stock worth $1,397,000 after acquiring an additional 22,471 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have weighed in on KMTS. Royal Bank Of Canada set a $30.00 price objective on shares of Kestra Medical Technologies in a research report on Tuesday, September 15th. Oppenheimer initiated coverage on shares of Kestra Medical Technologies in a research report on Tuesday, July 21st. They set a “market perform” rating on the stock. Piper Sandler reissued an “overweight” rating on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Wall Street Zen lowered shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Saturday, September 12th. Finally, Evercore started coverage on shares of Kestra Medical Technologies in a research report on Tuesday. They issued an “outperform” rating and a $34.00 price objective for the company. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $29.00.

Kestra Medical Technologies Company Profile

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.